Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | RB1 | P06400 | 1/20 | 0.43 |
| ▸ | HTR5A | P47898 | 3/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16559077 | 0.79 | HTR2A (0.53) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL16559076 | 0.79 | HTR2A (0.53) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL6529682 | 0.79 | HTR2A (0.53) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL7406719 | 0.79 | HTR2A (0.53) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL7412311 | 0.78 | HTR6 (0.61) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL23876062 | 0.78 | DRD2 (0.62) | HTR2AHTR2CCYP2D6KDM4EMAOA | |
| SCHEMBL18070796 | 0.77 | HTR2A (0.50) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL21088785 | 0.77 | RB1 (0.51) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL10743921 | 0.75 | HTR2A (0.49) | HTR2AHTR2CCYP1A2CYP2D6KDM4E | |
| SCHEMBL14492880 | 0.73 | HTR2A (0.47) | HTR2AHTR2CCYP1A2CYP2D6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9523031-B2 | Organic electroluminescent device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-20 | — | — | US | disclosed |
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20070224448-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070224448-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070190355-A1 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070190355-A1 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1808433-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2007-07-18 | — | — | EP | disclosed |
| US-20070009760-A1 | Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device | INOUE TETSUYA | 2007-01-11 | — | — | US | disclosed |
| US-20070009760-A1 | Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device | INOUE TETSUYA | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | INTS9, KCNN2, KCNH3 | HTR2A 2570/4885HTR2C 1590/4885CYP1A2 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.